+226.3%
CLSK vs PSA
+22.3%
+204.0%
-71.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | +0.6% | +6.2% | +6.5% |
| 7D | +7.7% | -1.8% | +9.5% | +8.6% |
| 30D | +12.2% | -8.4% | +20.6% | +16.6% |
| 3M | -15.5% | -7.8% | -7.6% | -13.6% |
| 6M | +39.3% | +0.8% | +38.6% | +34.3% |
| YTD | +35.1% | +16.5% | +18.6% | +20.6% |
| 1Y | +34.0% | +4.7% | +29.3% | +26.4% |
| 3Y | +226.3% | +21.1% | +205.2% | +162.5% |
| All | +226.3% | +22.3% | +204.0% | +162.5% |
Cumulative growth
Daily Returns
Daily percentage return beside PSA.
Daily Out/Under-Performance
Portfolio return minus PSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling